Regorafenib. | Recent Results Cancer Res;201: 185-96, 2014. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Search Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Regorafenib.

Ettrich, Thomas J; Seufferlein, Thomas.

Affiliation

Ettrich TJ; Department of Internal Medicine I, University of Ulm, Albert-Einstein-Allee 23, 89081, Ulm, Germany, thomas.seufferlein@uniklinik-ulm.de.

Recent Results Cancer Res ; 201: 185-96, 2014.

Article in En | MEDLINE | ID: mdl-24756792

Subject(s)

Antineoplastic Agents/therapeutic use; Neoplasms/drug therapy; Phenylurea Compounds/therapeutic use; Pyridines/therapeutic use; Animals; Humans; Protein Kinase Inhibitors/therapeutic use

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Pyridines / Neoplasms / Antineoplastic Agents Type of study: Clinical_trials Limits: Animals / Humans Language: En Journal: Recent Results Cancer Res Year: 2014 Type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Pyridines / Neoplasms / Antineoplastic Agents Type of study: Clinical_trials Limits: Animals / Humans Language: En Journal: Recent Results Cancer Res Year: 2014 Type: Article